Kronox Lab Sciences Ltd (KRONOX) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 544187 | NSE: KRONOX | Chemicals | Small Cap

Kronox Lab Sciences Share Price

138.25 -0.10 -0.07%
as on 05-Dec'25 15:25

Kronox Lab Sciences Ltd (KRONOX) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 544187 | NSE: KRONOX | Chemicals | Small Cap

DeciZen - make an informed investing decision on Kronox Lab Sciences

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Kronox Lab Sciences stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
19.90
Market Cap:
513.3 Cr.
52-wk low:
130.1
52-wk high:
228.6

Is Kronox Lab Sciences Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Kronox Lab Sciences: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Kronox Lab Sciences Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 50.7%55.3%51.6%51.5%43.8%-
Value Creation
Index
2.63.02.72.72.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 62.582.395.689.9100100
Sales YoY Gr.-31.7%16.2%-6%11.5%-
Adj EPS 2.53.44.25.76.87
YoY Gr.-39.4%23.6%34.7%19.3%-
BVPS (₹) 6.910.312.117.924.327.3
Adj Net
Profit
9.613.415.721.225.326
Cash Flow from Ops. 11.3919.717.430.7-
Debt/CF from Ops. 00.1000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA6.8%11.5%
Adj EPS NANA25.7%19.3%
BVPSNANA32.9%35.9%
Share Price - - - -29.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
35.839.93738.232.326.9
Op. Profit
Mgn %
23.72422.731.533.132.7
Net Profit
Mgn %
15.416.316.523.625.225.8
Debt to
Equity
000000
Working Cap
Days
0151146157190126
Cash Conv.
Cycle
069706758110

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Kronox Lab Sciences Ltd.

Standalone Consolidated
TTM EPS (₹) 7 -
TTM Sales (₹ Cr.) 100 -
BVPS (₹.) 27.3 -
Reserves (₹ Cr.) 64 -
P/BV 5.06 -
PE 19.90 -
From the Market
52 Week Low / High (₹) 130.05 / 228.55
All Time Low / High (₹) 130.05 / 228.55
Market Cap (₹ Cr.) 513
Equity (₹ Cr.) 37.1
Face Value (₹) 10
Industry PE 48.1

Management X-Ray of Kronox Lab Sciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Kronox Lab Sciences - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Kronox Lab Sciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Sales62829690100
Operating Expenses 4863746267
Manufacturing Costs44568
Material Costs3447554651
Employee Cost 12233
Other Costs 791275
Operating Profit 1520222833
Operating Profit Margin (%) 23.7%23.9%22.7%31.5%33.1%
Other Income 11223
Interest 00000
Depreciation 22111
Exceptional Items 00000
Profit Before Tax 1318222934
Tax 35679
Profit After Tax 1014162125
PAT Margin (%) 15.6%16.6%17.2%23.8%25.4%
Adjusted EPS (₹)2.53.54.45.86.9
Dividend Payout Ratio (%)0%0%0%9%7%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 2740456690
Share Capital 00373737
Reserves 274082953
Minority Interest00000
Debt00000
Long Term Debt00000
Short Term Debt00000
Trade Payables712867
Others Liabilities 44111
Total Liabilities 3756547498

Fixed Assets

Gross Block1822263740
Accumulated Depreciation910101112
Net Fixed Assets 911162628
CWIP 00001
Investments 00000
Inventories58996
Trade Receivables1526191820
Cash Equivalents 23448
Others Assets 5971635
Total Assets 3756547498

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 119201731
PBT 1318222934
Adjustment 2211-0
Changes in Working Capital -1-72-45
Tax Paid -4-5-6-7-9
Cash Flow From Investing Activity -3-8-7-17-28
Capex -2-4-8-12-3
Net Investments -2-40-6-27
Others 00112
Cash Flow From Financing Activity -7-1-130-2
Net Proceeds from Shares 00000
Net Proceeds from Borrowing 00000
Interest Paid -0-0-000
Dividend Paid 0000-2
Others -7-0-1300
Net Cash Flow 11-000

Finance Ratio

PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)36.2940.5838.5538.4532.56
ROCE (%)50.7155.3251.6351.5243.82
Asset Turnover Ratio1.671.751.731.411.16
PAT to CFO Conversion(x)1.10.641.250.811.24
Working Capital Days
Receivable Days9092857468
Inventory Days3229323728
Payable Days7070645749

Kronox Lab Sciences Ltd Stock News

Kronox Lab Sciences Ltd FAQs

The current trading price of Kronox Lab Sciences on 05-Dec-2025 15:25 is ₹138.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Kronox Lab Sciences stood at ₹513.3.
The latest P/E ratio of Kronox Lab Sciences as of 04-Dec-2025 is 19.90.
The latest P/B ratio of Kronox Lab Sciences as of 04-Dec-2025 is 5.06.
The 52-week high of Kronox Lab Sciences is ₹228.6 and the 52-week low is ₹130.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Kronox Lab Sciences is ₹99.96 ( Cr.) .

About Kronox Lab Sciences Ltd

The company was incorporated on November 18, 2008 as 'Kronox Lab Sciences Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated November 18, 2008 issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, the company was converted into a public limited company pursuant to a resolution passed by its shareholders at an extra-ordinary general meeting held on May 25, 2019 and a fresh certificate of incorporation dated June 11, 2019 was issued by the Registrar of Companies, Ahmedabad consequent upon conversion, recording the change in the name of the company to 'Kronox Lab Sciences Limited'.   

The company manufactures High Purity Speciality Fine Chemicals for diversified end user industries. Its High Purity Speciality Fine Chemicals are used mainly as (i) reacting agents and raw material in the manufacturing of Active Pharmaceutical Ingredients (APIs); (ii) excipients in pharmaceutical formulations; (iii) reagents for scientific research and laboratory testing; (iv) ingredients in nutraceuticals formulations; (v) process intermediates and fermenting agents in biotech applications; (vi) ingredients in agrochemical formulations; (vii) ingredients in personal care products; (viii) refining agents in metal refineries; and (ix) ingredients in animal health products, amongst others. Its products are manufactured in accordance with industry standards like IP, BP, EP, JP, USP, FCC, LR, AR, GR and ACS in addition to custom manufacturing specifications, which differ from the industry standards, required by its customers in select cases. It manufactures High Purity Speciality Fine Chemicals of various grades in particle sizes ranging from 10 mesh to 100 mesh. Its focus on product development, diversity in product offerings, meeting quality standards and customer specifications and continuous process improvement has led to repeat orders from its customers over the years.

In addition to the manufacturing of products in accordance with various domestic and international standards, it also undertakes custom manufacturing to achieve high levels of purity, as specified by the client, having different purity levels than the prescribed industry standards. Custom manufacturing requires deep domain knowledge, expertise and understanding of the characteristics of each chemical and its compounds, including decreasing the level of existing impurities and the processes to be deployed to reach the desired level of purity. It has set up an in-house research, development and testing laboratory (RDT Laboratory) to develop new products and test its products against the specified industry standards or customer specifications. Its dedicated RDT Laboratory is located in Unit I with the objective to implement a performance-oriented approach with the help of advanced equipment and systems. Its RDT Laboratory is equipped with the necessary facilities to carry out tests required to develop the products. 

Business area of the company

The company is a bulk manufacturer of high purity fine chemicals, in compliance with Reagent, Pharmacopoeia and various Food Grade standards, for the pharmaceutical, nutraceutical, veterinary, food, chemical analysis and other specialty markets. 

Major events:

  • 2008: Incorporation of the company.
  • 2009: Commencement of manufacturing of High Purity Speciality Fine Chemicals at Unit I.
  • 2010: Commenced export of products.
  • 2011: The company expanded its Unit I for manufacturing of High Purity Speciality Fine Chemicals used in pharmaceutical and nutraceutical industries.
  • 2011: The company started manufacturing High Purity Speciality Fine Chemicals to cater to the solar industries.
  • 2014: Acquisition of land along with factory shed for Unit II.
  • 2014: Receipt of FSSC 22000 certification from ISOQAR, UK for Unit I.
  • 2015: Commencement of manufacturing operations at Unit II.
  • 2015: Obtained FSSAI certification for manufacturing of food grade fine chemicals and ingredients.
  • 2017: Receipt of ISO 14001: 2015 & OHSAS 18001:2007 certification in respect of Unit I.
  • 2019: Started manufacturing of products at its Unit III.
  • 2022: Acquisition of land along with factory shed for Unit I and Unit III.
  • 2023: Acquisition of land for proposed Unit IV.


To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×